Shagun Singh
Stock Analyst at RBC Capital
(3.38)
# 962
Out of 5,165 analysts
251
Total ratings
50.72%
Success rate
1.5%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Sector Perform | $115 → $125 | $109.00 | +14.68% | 24 | Feb 27, 2026 | |
| INSP Inspire Medical Systems | Maintains: Sector Perform | $90 → $68 | $55.15 | +23.30% | 10 | Feb 12, 2026 | |
| BDX Becton, Dickinson and Company | Maintains: Sector Perform | $210 → $172 | $161.64 | +6.41% | 5 | Feb 10, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $130 → $115 | $71.20 | +61.52% | 19 | Feb 5, 2026 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $240 → $255 | $238.11 | +7.09% | 24 | Feb 3, 2026 | |
| ABT Abbott Laboratories | Maintains: Outperform | $147 → $135 | $110.71 | +21.94% | 18 | Jan 23, 2026 | |
| PEN Penumbra | Downgrades: Sector Perform | $355 → $374 | $338.00 | +10.65% | 16 | Jan 20, 2026 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $625 → $650 | $482.76 | +34.64% | 18 | Dec 17, 2025 | |
| GMED Globus Medical | Maintains: Outperform | $92 → $100 | $88.16 | +13.43% | 9 | Dec 17, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $95 → $100 | $84.27 | +18.67% | 24 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $370 → $380 | $230.49 | +64.87% | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $111 → $118 | $88.44 | +33.42% | 22 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $22 → $17 | $3.61 | +370.91% | 14 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $111 → $101 | $92.52 | +9.17% | 17 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $85 | $67.32 | +26.26% | 5 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $25 | $23.91 | +4.56% | 3 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $349.11 | +24.60% | 19 | Jan 29, 2025 |
Teleflex
Feb 27, 2026
Maintains: Sector Perform
Price Target: $115 → $125
Current: $109.00
Upside: +14.68%
Inspire Medical Systems
Feb 12, 2026
Maintains: Sector Perform
Price Target: $90 → $68
Current: $55.15
Upside: +23.30%
Becton, Dickinson and Company
Feb 10, 2026
Maintains: Sector Perform
Price Target: $210 → $172
Current: $161.64
Upside: +6.41%
Boston Scientific
Feb 5, 2026
Maintains: Outperform
Price Target: $130 → $115
Current: $71.20
Upside: +61.52%
Johnson & Johnson
Feb 3, 2026
Maintains: Outperform
Price Target: $240 → $255
Current: $238.11
Upside: +7.09%
Abbott Laboratories
Jan 23, 2026
Maintains: Outperform
Price Target: $147 → $135
Current: $110.71
Upside: +21.94%
Penumbra
Jan 20, 2026
Downgrades: Sector Perform
Price Target: $355 → $374
Current: $338.00
Upside: +10.65%
Intuitive Surgical
Dec 17, 2025
Maintains: Outperform
Price Target: $625 → $650
Current: $482.76
Upside: +34.64%
Globus Medical
Dec 17, 2025
Maintains: Outperform
Price Target: $92 → $100
Current: $88.16
Upside: +13.43%
Edwards Lifesciences
Dec 5, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $84.27
Upside: +18.67%
Nov 21, 2025
Maintains: Outperform
Price Target: $370 → $380
Current: $230.49
Upside: +64.87%
Nov 19, 2025
Maintains: Outperform
Price Target: $111 → $118
Current: $88.44
Upside: +33.42%
Nov 11, 2025
Maintains: Sector Perform
Price Target: $22 → $17
Current: $3.61
Upside: +370.91%
Nov 6, 2025
Maintains: Outperform
Price Target: $111 → $101
Current: $92.52
Upside: +9.17%
Oct 31, 2025
Maintains: Outperform
Price Target: $100 → $85
Current: $67.32
Upside: +26.26%
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $23.91
Upside: +4.56%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $349.11
Upside: +24.60%